Press Releases3rd International Portugal Medical Cannabis Conference (PTMC) To Take...

3rd International Portugal Medical Cannabis Conference (PTMC) To Take Place In Lisbon Next Week


CANNABIS helps children with Autism, Cancer, Epilepsy or even Psychosis and doctors will explain how next week in Lisbon, Portugal.

The growing trend towards the legalization of cannabis worldwide leaves no room for doubt: cannabis does, indeed, have the potential to treat various pathologies and more and more countries are opting for its regulation. However, the lack of information and training, particularly among health professionals, still prevents a broad use of this therapy, which can make all the difference in the quality of life of thousands of people.

This year, the 3rd International Conference on Medicinal Cannabis, PTMC, that takes place in Lisbon, on June 16th and 17th, will address the myths and facts associated with cannabis and psychosis, the therapeutic potential of cannabinoids in Pediatrics, especially in childhood diseases such as Autism, Cancer or Epilepsy. Bonni Goldstein, Pediatrician in Los Angeles, Dani Gordon, Physician in London or Carl Hart, Professor of Psychology in Psychiatry at Columbia University, in New York, are just some of the more than 20 speakers who will talk about their experience and show successful cases of treatment with cannabinoids.

Aiming to promote the access for health professionals and students to this information, PTMC will grant a 75% discount to health professionals or students who send a valid professional card to [email protected]

Portugal has established itself in recent years as the center of excellence for medical cannabis in Europe, with 18 companies already licensed and more than 80 with a pre-license granted by Infarmed, being one of the largest cannabis producers in the world and having exported more than 30 tonnes of cannabis flowers in 2021, an increase of 566% over the previous year.

The cannabis industry will generate the most jobs worldwide in the coming years, having already generated billions of euros of revenue in many countries. PTMC will also discuss the economic potential of cannabis, bringing CEO’s, analysts and consultants to talk about the businesses and investments associated with this millenary plant. Tej Virk, Akanda’s CEO, Alfredo Pascual, Vice-President of Investment Analysis at Seed Innovations, Jaime Gil-Robles, from AgroPharm, or Shlomo Booklin, from Juicy Fields, will be some of the speakers of the 2nd day of the Conference.

The two day’s event will finish with a business networking sunset party aboard a catamaran on the Tagus River, with a saxophone-DJ duo and an open bar with hemp-infused drinks and dinner.

PTMC – Portugal Medical Cannabis, organized by CannaReporter, a non-profit organization dedicated to disseminating more and better information about cannabis, has brought to Portugal, since 2018, the most important doctors, scientists and researchers, who discussed and demonstrated the latest advances in science regarding medical cannabis.

Latest news

Germany Seeing Sense, High Tide Strikes Deal With Major German Player, European Expansion For Bedrocan, Danish Buy-Out, Greek First, £2m UK Hemp Boost

THE German Government’s refreshingly honest approach to drugs and addiction is being demonstrated with a focus on the harms...

European Cannabis Stocks Review: Akanda Announces ‘First Significant Revenue Above Initial Projections’, Jazz Pharma Reimbursement Recommendation & Kanabo Climbs

Akanda  Akanda has enjoyed a sharp recovery in its share price this week, seeing its value return to levels not...

15% Of European Consumers Have Tried CBD, But Industry Held Back By ‘High Turnover Rate’ Of Users

THE European CBD market is set to see a ‘massive influx’ of previous and new consumers to the market...

Malta’s Pioneering Legal Cannabis Club Framework Announced, But Concerns Raised Licence Fees Could Push Many To Black Market

ON Friday (January 27) the Maltese Authority for the Responsible Use of Cannabis (ARUC) announced new guidelines set to...

Cannovum AG Establishes Cultivation Alliance For Germany

PRESS RELEASE CANNOVUM AG is currently founding the premier cultivation alliance for recreational cannabis in Germany. The aim of the...

Jazz Pharmaceuticals Receives NICE Recommendation For The Reimbursement Of Epidyolex (Cannabidiol) For The Treatment Of Seizures Associated With Tuberous Sclerosis Complex In England

PRESS RELEASE JAZZ Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Epidyolex® (cannabidiol,100 mg/mL oral solution), developed by GW Pharmaceuticals ("GW"; now...

Must read

You might also likeRELATED
Recommended to you